Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.66 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.66 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.66 |
| ▸ | HTR2C | P28335 | 1/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.66 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 7/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.66 |
| ▸ | USP2 | O75604 | 4/20 | 0.66 |
| ▸ | HTT | P42858 | 4/20 | 0.66 |
| ▸ | HAT1 | O14929 | 4/20 | 0.66 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | RECQL | P46063 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | CASP1 | P29466 | 2/20 | 0.66 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.66 |
| ▸ | CASP7 | P55210 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | TST | Q16762 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23074567 | 0.91 | ESR1 (0.69) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL2691658 | 0.90 | MEN1 (0.72) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL23074645 | 0.88 | ESR1 (0.60) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL27445923 | 0.87 | ESR1 (0.66) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL23074646 | 0.85 | ESR1 (0.56) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL18088262 | 0.83 | MEN1 (0.79) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL23074582 | 0.83 | ESR1 (0.54) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL23074610 | 0.83 | ESR1 (0.61) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| SCHEMBL27445695 | 0.82 | ESR1 (0.53) | ESR1NR3C1ADRB2HTR2CADRA1A | |
| Riboflavin SCHEMBL27897112 | 0.81 | MEN1 (0.79) | ESR1NR3C1ADRB2HTR2CADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | OHIO STATE INNOVATION FOUNDATION (US) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029790-B2 | Biomimetic nanomaterials and uses thereof | MTREX, HAVCR2, TSG101 | ESR1 1573/4885NR3C1 2201/4885ADRB2 4005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.